Recent News for BIOL - Biolase, Inc.

Date Title
Apr 16 Biolase: Risky Turnaround Play Still Mostly Suited For Traders
Apr 14 New Strong Sell Stocks for April 14th
Apr 8 2 “Strong Buy” Penny Stocks That Could See 100% Gains (Or More)
Mar 30 BIOLASE Announces Collaboration with Einstein Healthcare Network's Residency in Endodontics
Mar 26 The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
Mar 26 BIOLASE, Inc. (BIOL) CEO John Beaver on Q4 2020 Results - Earnings Call Transcript
Mar 25 Biolase EPS misses by $0.03, beats on revenue
Mar 25 BIOLASE Reports 31% Sequential Revenue Growth In 2020 Fourth Quarter; Demand From New Users Driving Positive Performance
Mar 25 Earnings Scheduled For March 25, 2021
Mar 20 FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
Mar 17 BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021
Mar 16 BIOLASE To Participate In Maxim Group's Inaugural 2021 Emerging Growth Virtual Investor Conference
Mar 3 BIOLASE Announces the Launch of Waterlase Perio Academy
Feb 24 BIOLASE To Participate In H.C. Wainwright Investor Conference
Feb 10 BIOLASE, Inc. Announces Closing Of $14.4 Million Bought Offering
Feb 8 BIOLASE Raises $14.4M From Maxim Group At 15% Discount
Feb 8 Biolase secures ~$14.4 capital raise
Feb 6 BIOLASE, Inc. Announces Pricing of $14.4 Million Bought Deal Offering
Feb 5 The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
Feb 4 Biolase shares jump 11% after regaining Nasdaq compliance
Feb 4 BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement And Cancels Special Meeting Of Stockholders
Feb 1 Biolase: Business Recovery On The Way But Warrant Overhang Should Keep Investors Sidelined
Feb 1 BIOLASE Urges Stockholders To Vote Today "FOR" The Reverse Stock Split
Jan 30 10 Best Dental Stocks to Buy Now
Jan 28 98 Biggest Movers From Yesterday
Back to the Main BIOL Page...